Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03984929 · ClinicalTrials.gov registry record · NA
Conexion: A Localized Information Resource on Diabetes and Depression for a Low-income Hispanic Community
A NA study of Depression and Diabetes Mellitus, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
- 2
- Study locations
NCT03984929: Completed NA study of Depression and Diabetes Mellitus, sponsored by Columbia University.
NCT03984929 is a NA study of Depression and Diabetes Mellitus that has completed, run by Columbia University. The registered enrollment target is 136 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03984929, a NA study of Depression and Diabetes Mellitus, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
- 2
- Study locations
Study Summary
The proposed Conexion resource combines best publicly available evidence-based information and local community resources in one place. The information is curated and contextualized to meet local needs of consumers and providers. Content is tailored culturally and geographically to fit the community. This approach is consistent with evidence showing that individuals' interactions with health information and technology are "community embedded".
Primary Outcome
Person's active engagement in management of their own health will be measured as a patient activation measure (PAM) score. The PAM is a validated scale with 13 questions. The score ranges from 0 to 100, with a higher score indicating a better outcome.
Conditions Studied
Interventions
- BEHAVIORAL Conexion Localized
- BEHAVIORAL Conexion Generic
Study Locations (2)
New York
- Isabella Geriatric Center - New York
- YM-YWHA of Washington Heights - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2022-08-15 |
| Phase | NA |
What the finished NCT03984929 record still lists
NCT03984929 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Conexion Localized is the first listed.
NCT03984929 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03984929 about?
NCT03984929 is a clinical study titled "Conexion: A Localized Information Resource on Diabetes and Depression for a Low-income Hispanic Community". The proposed Conexion resource combines best publicly available evidence-based information and local community resources in one place. The information is curated and contextualized to meet local needs of consumers and providers. Content is tailored culturally and geographically to fit the community....
What is the current status of trial NCT03984929?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2019-06-01. Estimated completion is 2022-08-15.
What conditions does trial NCT03984929 study?
This clinical trial studies the following conditions: Depression, Diabetes Mellitus.
What interventions are being tested in trial NCT03984929?
The interventions under investigation include: Conexion Localized (BEHAVIORAL), Conexion Generic (BEHAVIORAL).
Who is sponsoring clinical trial NCT03984929?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03984929 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03984929's enrollment target sits among peer trials
136 275th of 679 higher than 404 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy